Health, Medical & Pharma News - Updated Daily page 36

Thyroid Eye Disease Tied to Higher Prevalence of Human Papillomavirus

Patients with thyroid eye disease (TED) have a higher prevalence of low-risk human papillomavirus (HPV) diagnosed before autoimmune hyperthyroidism onset than m

Menopausal Hormone Therapy Not Linked to Increased Mortality Risk

Menopausal hormone therapy is not associated with an increased risk for mortality, according to a study published online Feb. 18 in The BMJ. Anders Pretzmann Mi

Living in Closer Proximity to Nuclear Power Plants May Increase Cancer Mortality Risk

Counties located closer to operational nuclear power plants have higher cancer mortality rates, according to a study published online Feb. 23 in Nature Communic

Umeclidinium-Vilanterol Tied to Better Outcomes Than Other LAMA-LABA Inhalers in Symptomatic COPD

Umeclidinium-vilanterol is associated with improved clinical outcomes compared with glycopyrrolate-formoterol and tiotropium-olodaterol in symptomatic patients

Improved Survival Seen for Stage IV Breast Cancer Detected Via Screening

Screening detection is associated with increased survival rates even for stage IV breast cancer, according to a study published online Feb. 19 in the Journal of

Palvella Therapeutics Announces Positive Topline Results from Phase 3 SELVA Clinical Study of QTORIN™ 3.9% Rapamycin Anhydrous Gel in Microcystic Lymphatic Malformations

(Nasdaq PVLA) Palvella Therapeutics, Inc. (Palvella or the Company ), a clinical-stage biopharmaceutical company focused on developing and commercializing novel

Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann Pick Disease Type C

U.S. FDA Grants Full Approval to Pfizer’s Braftovi Combination Regimen in First-Line Metastatic Colorectal Cancer

Novo Nordisk Announces Significant Reduction in US List Price for Wegovy, Ozempic, and Rybelsus (semaglutide medicines), Building on Continued Efforts to Expand Access

Plainsboro, NJ, US and Bagsv rd, Denmark, February 24, 2026 Today, Novo Nordisk announced that, effective January 1, 2027, the company will lower the list price

Pharmaceutical News and Articles